Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al
Endocrinology
.
2013 Nov;154(11):3957-60.
doi: 10.1210/en.2013-1854.
Epub 2013 Sep 18.
Authors
A C Gore
1
,
J Balthazart
,
D Bikle
,
D O Carpenter
,
D Crews
,
P Czernichow
,
E Diamanti-Kandarakis
,
R M Dores
,
D Grattan
,
P R Hof
,
A N Hollenberg
,
C Lange
,
A V Lee
,
J E Levine
,
R P Millar
,
R J Nelson
,
M Porta
,
M Poth
,
D M Power
,
G S Prins
,
E C Ridgway
,
E F Rissman
,
J A Romijn
,
P E Sawchenko
,
P D Sly
,
O Söder
,
H S Taylor
,
M Tena-Sempere
,
H Vaudry
,
K Wallen
,
Z Wang
,
L Wartofsky
,
C S Watson
Affiliation
1
PhD, Editor-in-Chief, Endocrinology, Gustavus, Louise Pfeiffer Professor of Pharmacology, Toxicology, The University of Texas at Austin, Austin, Texas 78712. andrea.gore@austin.utexas.edu.
PMID:
24048095
PMCID:
PMC5398595
DOI:
10.1210/en.2013-1854
No abstract available
Publication types
Comment
MeSH terms
Advisory Committees*
Animals
Endocrine Disruptors / standards*
Endocrine Disruptors / toxicity*
Humans
Substances
Endocrine Disruptors
Grants and funding
R01 AR038386/AR/NIAMS NIH HHS/United States
R01 AR050023/AR/NIAMS NIH HHS/United States
R01 HD068777/HD/NICHD NIH HHS/United States